Recursion Pharmaceuticals call volume above normal and directionally bullish
Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 12,155 calls trading, 1.0x expected, and implied vol increasing almost 2 ...
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
My Central Oregon15h
Purdue Pharma, Sackler families boost contribution in opioid settlement to $7.4 billion
Purdue Pharma headquarters; Victor J. Blue/Bloomberg via Getty Images(NEW YORK) -- The company and once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribut ...
infectiousdiseaseadvisor.com17h
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
Why I Don’t Believe Larry Ellison’s Moderna Stock Hype
MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...